Bayforest Capital’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-307
Closed -$47.3K – 914
2026
Q2
$47.3K Buy
+307
New +$47.1K 0.04% 635

Other funds holding BLTE

Bayforest Capital's BLTE Position: Q3 2026 in Review

Bayforest Capital sold out of Belite Bio (BLTE) in Q3 2026, closing a stake of 307 shares — an estimated $47.3K sold.

Bayforest Capital first reported a position in BLTE in Q2 2026 and held it in 1 quarter. The position peaked at $47.3K in Q2 2026. 63 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Bayforest Capital reported no remaining Belite Bio position as of Q3 2026 after selling out during the quarter.
  • Bayforest Capital sold 307 Belite Bio shares in Q3 2026, an estimated $47.3K.
  • Bayforest Capital first reported a position in Belite Bio in Q2 2026 and held it in 1 quarter.
  • Bayforest Capital's Belite Bio position peaked at $47.3K in Q2 2026.
  • 63 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.